This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Toll-like Receptor 3D structures

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:29, 27 December 2023) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
==3D Structures of Toll-like Receptors==
==3D Structures of Toll-like Receptors==
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} - For a general description of the protein see [[Toll-like Receptor]]
+
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} - For a general description of the protein see [[Toll-like Receptors]]
{{#tree:id=OrganizedByTopic|openlevels=0|
{{#tree:id=OrganizedByTopic|openlevels=0|
-
*Toll-like receptor 1
+
*Toll-like receptor 1; Domains – Transmembrane+juxtamembrane 581-629; TIR 625-785; ligand-binding (LBD) 22-703; transmembrane 698-730
**[[1fyv]] – hTLR1 TIR domain – human<br />
**[[1fyv]] – hTLR1 TIR domain – human<br />
 +
**[[6nih]] - hTLR1/VLRB.61<br />
**[[2z7x]], [[2z81]], [[2z82]] – hTLR1/VLRB.61 + hTLR2/VLRB.61 + lipopeptide
**[[2z7x]], [[2z81]], [[2z82]] – hTLR1/VLRB.61 + hTLR2/VLRB.61 + lipopeptide
*Toll-like receptor 2
*Toll-like receptor 2
-
**[[1fyw]] – hTLR2 TIR domain<br />
+
**[[8ar0]], [[8ar1]], [[8ar2]], [[8ar3]] – hTLR2 transmembrane+juxtamembrane domain – NMR<br />
 +
**[[1fyw]], [[7nux]], [[7nux]] – hTLR2 TIR domain<br />
 +
**[[7nt7]] – hTLR1 TIR domain – NMR<br />
**[[1fyx]], [[1o77]] - hTLR2 TIR domain (mutant) <br />
**[[1fyx]], [[1o77]] - hTLR2 TIR domain (mutant) <br />
**[[2z80]] – hTLR2/VLRB.61<br />
**[[2z80]] – hTLR2/VLRB.61<br />
**[[3a79]] – hTLR2/VLRB.61 + hTLR6/VLRB.61 + lipopeptide<br />
**[[3a79]] – hTLR2/VLRB.61 + hTLR6/VLRB.61 + lipopeptide<br />
 +
**[[6nig]] – hTLR2/VLRB.61 + diprovocim<br />
**[[3a7b]] - mTLR2/VLRB.61 – mouse<br />
**[[3a7b]] - mTLR2/VLRB.61 – mouse<br />
**[[3a7c]] - mTLR2/VLRB.61 + PE-DTPA<br />
**[[3a7c]] - mTLR2/VLRB.61 + PE-DTPA<br />
Line 21: Line 25:
*Toll-like receptor 3
*Toll-like receptor 3
-
**[[1ziw]], [[2a0z]] – hTLR3 ligand-binding domain<br />
+
**[[1ziw]], [[2a0z]] – hTLR3 LBD<br />
**[[5gs0]] – hTLR3 ectodomain + antibody<br />
**[[5gs0]] – hTLR3 ectodomain + antibody<br />
**[[2mk9]], [[2mka]] – hTLR3 transmembrane domain - NMR <br />
**[[2mk9]], [[2mka]] – hTLR3 transmembrane domain - NMR <br />
-
**[[3cig]] – mTLR3 ectodomain<br />
+
**[[3ulv]], [[3ulu]], [[5gs0]] – hTLR3 LBD + antibody<br />
-
**[[3ciy]] - mTLR3 ectodomain + RNA<br />
+
**[[7c76]] – hTLR3 + UNC93B1 – Cryo EM<br />
 +
**[[7wm4]], [[7wv3]], [[7wv4]], [[7wv5]], [[7wvj]] – hTLR3 LBD + RNA – Cryo EM<br />
 +
**[[7wve]] – hTLR3 LBD (mutant) + RNA – Cryo EM<br />
 +
**[[7wvf]] – hTLR3 LBD + antibody + RNA – Cryo EM<br />
 +
**[[7c77]] – mTLR3 + UNC93B1 – Cryo EM<br />
 +
**[[7da7]], [[7das]] – mTLR3 LBD + RNA – Cryo EM<br />
 +
**[[3cig]] – mTLR3 LBD<br />
 +
**[[3ciy]] - mTLR3 LBD + RNA<br />
*Toll-like receptor 4
*Toll-like receptor 4
Line 32: Line 43:
**[[3ul8]], [[3ul7]] – hTLR4/VLRB.61 (mutant)<br />
**[[3ul8]], [[3ul7]] – hTLR4/VLRB.61 (mutant)<br />
**[[5nam]], [[5nao]] – hTLR4 transmembrane domain - NMR<br />
**[[5nam]], [[5nao]] – hTLR4 transmembrane domain - NMR<br />
-
**[[3fxi]], [[4g8a]] - hTLR4 extracellular domain + lymphocyte antigen 96<br />
+
**[[3fxi]], [[4g8a]] - hTLR4 LBD + lymphocyte antigen 96<br />
**[[3ula]] - hTLR4/VLRB.61 + lymphocyte antigen 96<br />
**[[3ula]] - hTLR4/VLRB.61 + lymphocyte antigen 96<br />
-
**[[2z64]], [[2z65]], [[5ijc]], [[5ijd]], [[3vq1]], [[3vq2]] – mTLR4 extracellular domain+ lymphocyte antigen 96<br />
+
**[[2z64]], [[2z65]], [[5ijc]], [[5ijd]], [[3vq1]], [[3vq2]] – mTLR4 LBD + lymphocyte antigen 96<br />
 +
**[[7mlm]] - mTLR4/VLRB.61 + lymphocyte antigen 96 + sulfatide<br />
 +
 
 +
*Toll-like receptor 5
 +
 
 +
**[[3j0a]] – hTLR5<br />
 +
 
 +
*Toll-like receptor 5A
 +
 
 +
**[[7b1b]], [[7b1c]], [[7b1d]] – TLR5A + Spz1C – yellow fever mosquito - Cryo EM<br />
*Toll-like receptor 5B
*Toll-like receptor 5B
Line 41: Line 61:
**[[6bxa]] – zfTLR5B N-terminal + VLR2 <br />
**[[6bxa]] – zfTLR5B N-terminal + VLR2 <br />
**[[6bxc]] – zfTLR5B N-terminal + VLR9 <br />
**[[6bxc]] – zfTLR5B N-terminal + VLR9 <br />
-
**[[3v44]] – zfTLR5B/VLRB.61 <br />
+
**[[3v44]], [[6bxa]], [[6bxc]] – zfTLR5B/VLRB.61 <br />
**[[3v47]] – zfTLR5B/VLRB.61 + flagellin<br />
**[[3v47]] – zfTLR5B/VLRB.61 + flagellin<br />
Line 50: Line 70:
*Toll-like receptor 7
*Toll-like receptor 7
-
**[[5gmf]] – mTLR7 + guanosine + poly-U - monkey <br />
+
**[[7cyn]] – hTLR7 + UNC93B1 – Cryo EM<br />
-
**[[5gmg]] – mTLR7 + loxoribine + poly-U <br />
+
**[[5gmf]] – moTLR7 + guanosine + poly-U - monkey <br />
-
**[[5gmh]] – mTLR7 + resiquimod + poly-U <br />
+
**[[5gmg]] – moTLR7 + loxoribine + poly-U <br />
 +
**[[5gmh]] – moTLR7 + resiquimod + poly-U <br />
 +
**[[5zsl]], [[5zsm]], [[5zsn]] – moTLR7 (mutant) + RNA <br />
 +
**[[5zsg]], [[5zsh]], [[5zsi]], [[5zsj]], [[6lvz]], [[6lw1]], [[7ytp]] – moTLR7 (mutant) + inhibitor<br />
 +
**[[6lvx]], [[6lvy]], [[6lw0]] – moTLR7 (mutant) + antagonist<br />
 +
**[[6if5]] – moTLR7 (mutant) + cGMP<br />
 +
**[[5zsf]] – moTLR7 (mutant) + drug<br />
 +
**[[5zsa]], [[5zsb]], [[5zsd]], [[5zse]] – moTLR7 (mutant) + RNA + inhibitort<br />
*Toll-like receptor 8
*Toll-like receptor 8
**[[3w3g]], [[5hdh]] – hTLR8 <br />
**[[3w3g]], [[5hdh]] – hTLR8 <br />
-
**[[3w3j]], [[3w3k]], [[3w3l]], [[3w3m]], [[3w3n]], [[3wn4]], [[5awa]], [[5awc]], [[5awb]], [[5awd]], [[4r6a]], [[4qbz]], [[4qc0]], [[5az5]] – hTLR8 + agonist<br />
+
**[[3w3j]], [[3w3k]], [[3w3l]], [[3w3m]], [[3w3n]], [[3wn4]], [[5awa]], [[5awc]], [[5awb]], [[5awd]], [[4r6a]], [[4qbz]], [[4qc0]], [[5az5]], [[6v9u]], [[6wml]], [[6zjz]], [[7crf]], [[7r52]], [[7r53]], [[7r54]] – hTLR8 + agonist<br />
 +
**[[6kya]], [[6ty5]], [[7rc9]], [[7ytx]], [[8pfi]] – hTLR8 + antagonist<br />
**[[4r07]], [[4r09]] – hTLR8 + ORN06 <br />
**[[4r07]], [[4r09]] – hTLR8 + ORN06 <br />
**[[4r08]] – hTLR8 + RNA <br />
**[[4r08]] – hTLR8 + RNA <br />
Line 70: Line 98:
**[[3wpg]], [[3wph]], [[3wpi]] – mTLR9 + DNA <br />
**[[3wpg]], [[3wph]], [[3wpi]] – mTLR9 + DNA <br />
**[[5zln]] – mTLR9 (mutant) + DNA <br />
**[[5zln]] – mTLR9 (mutant) + DNA <br />
 +
**[[4qdh]] – mTLR9/VLRB.61 <br />
*Toll-like receptor 10
*Toll-like receptor 10
Line 78: Line 107:
**[[4z0c]] – mTLR13 + RNA <br />
**[[4z0c]] – mTLR13 + RNA <br />
 +
 +
*Toll-like receptor 15
 +
 +
**[[7ylf]], [[7ylg]] – TLR10 TIR domain - chicken<br />
}}
}}
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

3D Structures of Toll-like Receptors

Updated on 27-December-2023 - For a general description of the protein see Toll-like Receptors

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel

Retrieved from "http://52.214.119.220/wiki/index.php/Toll-like_Receptor_3D_structures"
Personal tools